Skip to search formSkip to main contentSkip to account menu

elvitegravir

Known as: elvitégravir, 6-(3-chloro-2-fluorobenzyl)-1-[(2S)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid, 6-(3-Chloro-2-fluorobenzyl)-1-((2S)-1-hydroxy-3-methylbutan-2-yl)-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid 
A modified quinolone antibiotic with activity against human immunodeficiency virus 1. Elvitegravir is an inhibitor of viral integrase and retains… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
Handling and shipping thin wafers (≦200μm) through all the semiconductor fabrication and packaging assembly processes are very… 
Highly Cited
2009
Highly Cited
2009
In this study we investigate the effects of unilateral voluntary contraction (VC) and electromyostimulation superimposed on VC… 
Highly Cited
2009
Highly Cited
2009
The treatment of HIV is often complicated by the emergence of antiretroviral (ARV) resistance, which has prompted the development… 
Highly Cited
1997
Highly Cited
1997
Purpose: To evaluate the anatomic morphology of abdominal aortic aneurysms (AAAs) and compose a classification system to… 
1997
1997
Endovascular grafts (EVGs) have been proposed as a treatment for a variety of vascular diseases; however, the impact of EVGs on…